Featured News
PRESS RELEASE
Provo-Orem, Utah Tops Milken Institute’s 2021 Ranking of Best-Performing Cities
California’s San Francisco and San Jose—in the top five last year—dropped to Tier 2 due to high housing costs and
March 4, 2021
News and Announcements
Newsroom
Featured News
PRESS RELEASE
Provo-Orem, Utah Tops Milken Institute’s 2021 Ranking of Best-Performing Cities
California’s San Francisco and San Jose—in the top five last year—dropped to Tier 2 due to high housing costs and
March 4, 2021
Featured News
PRESS RELEASE
Learned from COVID-19: How the Biomedical Research Community Can Expedite Innovation
March 4, 2021
Featured News
PRESS RELEASE
Milken Institute Asia Summit Kicks Off With Virtual, In Person, Hologram Features
The 2020 Asia Summit is one of the first in-person events in Singapore since the pandemic began, taking place Dec
March 4, 2021
Featured News
PRESS RELEASE
Milken Institute Future of Health Summit Opens Tomorrow, December 7
Albert Bourla, Anthony Fauci, Margaret Hamburg among 175+ speakers
March 4, 2021
Featured News
PRESS RELEASE
Governor of Tokyo Yuriko Koike to Speak at the 2020 Milken Institute Asia Summit | December 8 - 10
Governor Koike is scheduled for a one-on-one fireside chat session on Dec. 9
March 4, 2021
Featured News
PRESS RELEASE
Japan’s Prime Minister Suga To Deliver Video Address At Milken Institute Global Conference On October 19, 2020
The event marks only the second time PM Suga delivers address on an international stage
March 4, 2021
Featured News
Featured News
PRESS RELEASE
Milken Institute taps Hiromichi Mizuno as Special Advisor
With decades of finance experience, Mizuno will drive conversations on long-term investments and ESG.
March 4, 2021
Featured News
PRESS RELEASE
Milken Institute report examines Ultra-High Net-Worth Philanthropy, offers recommendations to spur giving
Washington D.C.
March 4, 2021
Featured News
PRESS RELEASE
Milken Institute COVID-19 tracker update identifies more than 100 vaccines and nearly 200 treatments in development
Nine vaccines and more than 50 treatment candidates currently in clinical trials.